The FDA has approved the Dermapace System for treatment of chronic, full-thickness diabetic foot ulcers.
Low-dose aspirin does not decrease healing time for patients with venous leg ulcers.
Clinicians missed several opportunities to advocate for their patient, leading to the loss of a leg.
Neuropathy is one of the most common diabetic comorbidities — affecting about 60% to 70% of patients. Managing glucose levels is the most direct way to prevent nerve damage and alleviate pain.